XRF Scientific - Public Comps and Valuation Multiples

XRF Scientific Overview

About XRF Scientific

XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.

Founded

2004

HQ

Employees

n/a

Website

xrfscientific.com

Sectors

Chemicals

Financials

LTM Revenue $39.9M

LTM EBITDA $11.0M

EV

$194M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

XRF Scientific Financials

As of August 2025, XRF Scientific reported last 12-month revenue of $39.9M and EBITDA of $11.0M.

In the same period, XRF Scientific achieved $7.0M in LTM net income.

See XRF Scientific valuation multiples based on analyst estimates

XRF Scientific P&L

In the most recent fiscal year, XRF Scientific reported revenue of $38.8M and EBITDA of $10.8M.

XRF Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX

See XRF Scientific valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$39.9M	XXX	$38.8M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$18.7M	XXX	XXX	XXX
Gross Margin	n/a	XXX	48%	XXX	XXX	XXX
EBITDA	$11.0M	XXX	$10.8M	XXX	XXX	XXX
EBITDA Margin	27%	XXX	28%	XXX	XXX	XXX
EBIT	$9.9M	XXX	$8.4M	XXX	XXX	XXX
EBIT Margin	25%	XXX	22%	XXX	XXX	XXX
Net Profit	$7.0M	XXX	$6.8M	XXX	XXX	XXX
Net Margin	18%	XXX	18%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for XRF Scientific including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $39.9M. EBITDA for the last twelve months was $11.0M. In the most recent fiscal year, XRF Scientific achieved $38.8M in revenue and $10.8M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$39.9M	Analyst estimates available to subscribers	$38.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$18.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	48.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$11.0M	Analyst estimates available to subscribers	$10.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	27.4% EBITDA margin	Analyst estimates available to subscribers	27.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$9.9M	Analyst estimates available to subscribers	$8.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	24.8% EBIT margin	Analyst estimates available to subscribers	21.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$7.0M	Analyst estimates available to subscribers	$6.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	17.6% net profit margin	Analyst estimates available to subscribers	17.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for XRF Scientific

This financial data table provides comprehensive performance metrics for XRF Scientific, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

XRF Scientific generated $39.9M in revenue over the last twelve months.
The company achieved $11.0M in EBITDA over the last twelve months.
Net income over the last twelve months reached $7.0M.

Fiscal Year Performance

In the most recent fiscal year, XRF Scientific reported $38.8M in total revenue.
Fiscal year EBITDA was $10.8M.
The company maintained a gross profit margin of 48.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 27.9%.
Net profit margin reached 17.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for XRF Scientific. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

XRF Scientific Stock Performance

XRF Scientific has current market cap of AUD 306M (or $201M), and EV of AUD 297M (or $194M).

Market Cap Evolution

XRF Scientific Stock Data

As of September 19, 2025, XRF Scientific's stock price is AUD 2 (or $1).

See XRF Scientific trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$194M	$201M	XXX	XXX	XXX	XXX	$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

XRF Scientific Valuation Multiples

XRF Scientific's trades at 5.0x EV/Revenue multiple, and 18.6x EV/EBITDA.

See valuation multiples for XRF Scientific and 15K+ public comps

XRF Scientific Financial Valuation Multiples

As of September 19, 2025, XRF Scientific has market cap of $201M and EV of $194M.

Equity research analysts estimate XRF Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

XRF Scientific has a P/E ratio of 28.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$201M	XXX	$201M	XXX	XXX	XXX
EV (current)	$194M	XXX	$194M	XXX	XXX	XXX
EV/Revenue	4.9x	XXX	5.0x	XXX	XXX	XXX
EV/EBITDA	17.8x	XXX	18.6x	XXX	XXX	XXX
EV/EBIT	19.6x	XXX	24.0x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	28.6x	XXX	31.8x	XXX	XXX	XXX
EV/FCF	32.0x	XXX	41.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get XRF Scientific Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

XRF Scientific Margins & Growth Rates

XRF Scientific's last 12 month revenue growth is 11%

XRF Scientific's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

XRF Scientific's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

XRF Scientific's rule of X is 55% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for XRF Scientific and other 15K+ public comps

XRF Scientific Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	11%	XXX	8%	XXX	XXX	XXX
EBITDA Margin	27%	XXX	27%	XXX	XXX	XXX
EBITDA Growth	13%	XXX	11%	XXX	XXX	XXX
Rule of 40	38%	XXX	38%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	55%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	26%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial